SEC Comment Letter to AIM ImmunoTech Inc. (AIM)
AIM ImmunoTech Inc.
Date: June 12, 2026 · CIK: 0000946644 · Accession: 0000000000-26-005945
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-296588
Letter
Re: AIM ImmunoTech Inc. Registration Statement on Form S-1 Filed June 08, 2026 File No. 333-296588 Dear Thomas Equels: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Daniel Crawford at 202-551-7767 with any questions.
June 12, 2026
Thomas Equels Chief Executive Officer AIM ImmunoTech Inc. 2117 SW Highway 484 Ocala, FL 34473
Sincerely,
Division of
Corporation Finance
Office of Life
Sciences
cc: Faith Charles, Esq.
Show Raw Text
<DOCUMENT>
<TYPE>TEXT-EXTRACT
<SEQUENCE>2
<FILENAME>filename2.txt
<TEXT>
June 12, 2026
Thomas Equels
Chief Executive Officer
AIM ImmunoTech Inc.
2117 SW Highway 484
Ocala, FL 34473
Re: AIM ImmunoTech Inc.
Registration Statement on Form S-1
Filed June 08, 2026
File No. 333-296588
Dear Thomas Equels:
This is to advise you that we have not reviewed and will not review your
registration
statement.
Please refer to Rules 460 and 461 regarding requests for acceleration.
We remind you that
the company and its management are responsible for the accuracy and adequacy of
their
disclosures, notwithstanding any review, comments, action or absence of action
by the staff.
Please contact Daniel Crawford at 202-551-7767 with any questions.
Sincerely,
Division of
Corporation Finance
Office of Life
Sciences
cc: Faith Charles, Esq.
</TEXT>
</DOCUMENT>